D
Xtant Medical Holdings, Inc. XTNT
$1.17 $0.076.36%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
D
Sell 11/17/2023Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D- on 11/17/2023 due to a significant increase in the efficiency index, total return index and growth index. Net income increased 521.51% from -$2.19M to $9.23M, earnings per share increased from -$0.0201 to $0.07, and total capital increased 42.54% from $54.52M to $77.71M.
D
Sell 3/14/2023Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
D
Sell 2/17/2023Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 2/17/2023 due to an increase in the volatility index and total return index.
D
Sell 11/7/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/7/2022 due to a large decline in the growth index and volatility index. Operating cash flow declined 13,860% from $15 to -$2.06M, earnings per share declined from -$0.02 to -$0.03, and EBIT declined 46.15% from -$1.3M to -$1.9M.
D
Sell 5/16/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 05/16/2022.
E
Sell 5/13/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 5/13/2022 due to a decline in the growth index and total return index. Operating cash flow declined 337.35% from $423 to -$1M, EBIT declined 10.23% from -$1.66M to -$1.83M, and total revenue declined 7.24% from $13.97M to $12.96M.
D
Sell 5/4/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
E
Sell 5/1/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 05/01/2022.
D
Sell 4/21/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell 4/20/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index.
D
Sell 3/15/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/15/2022 due to an increase in the growth index and solvency index. Operating cash flow increased 145.68% from -$926 to $423, and total revenue increased 1.4% from $13.78M to $13.97M.
D
Sell 11/8/2021Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index and valuation index. Earnings per share declined from -$0.0004 to -$0.01.
D
Sell 8/4/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 8/4/2020 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 111.91% from -$1.79M to $213, and EBIT increased 71.63% from -$1.36M to -$387.
D
Sell 7/30/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 7/30/2020 due to an increase in the volatility index and total return index.
E
Sell 7/15/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 7/15/2020 due to a decline in the volatility index.
D
Sell 6/26/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 6/26/2020 due to an increase in the volatility index, total return index and valuation index.
E
Sell 6/11/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 6/11/2020 due to a decline in the volatility index and valuation index.
D
Sell 5/27/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 5/27/2020 due to an increase in the volatility index.
E
Sell 5/8/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 5/8/2020 due to a substantial decline in the solvency index, growth index and efficiency index. Operating cash flow declined 2,419.72% from -$71 to -$1.79M, EBIT declined 328.93% from -$318 to -$1.36M, and net income declined 55.33% from -$1.61M to -$2.49M.
D
Sell 4/3/2019Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2019 due to a noticeable decline in the growth index, efficiency index and volatility index. Net income declined 1,698% from -$3.15M to -$56.69M, earnings per share declined from -$0.24 to -$4.3032, and EBIT declined 1,228.05% from -$385 to -$5.11M.
D
Sell 11/19/2018Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/19/2018 due to a large increase in the growth index, efficiency index and solvency index. EBIT increased 60.39% from -$972 to -$385, earnings per share increased from -$0.3823 to -$0.24, and net income increased 36.97% from -$5M to -$3.15M.
D
Sell 4/3/2018Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2018 due to a noticeable decline in the efficiency index, growth index and solvency index. EBIT declined 314.82% from -$1.36M to -$5.63M, net income declined 233.79% from -$8.51M to -$28.42M, and earnings per share declined from -$5.64 to -$18.7638.
D
Sell 11/22/2017Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/22/2017 due to an increase in the total return index, efficiency index and volatility index. Net income increased 12.16% from -$9.69M to -$8.51M.
D
Sell 3/31/2017Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/31/2017 due to a decline in the growth index, total return index and volatility index.
D
Sell 3/28/2016Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/28/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Net income increased 273.23% from -$6.69M to $11.59M, earnings per share increased from -$0.6412 to $0.9745, and operating cash flow increased 98.53% from -$4.94M to -$72.8.
D
Sell 3/11/2016Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell 1/12/2016Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
D
Sell 12/28/2015Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D on 12/28/2015 due to an increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.74 to 1.27.
Weiss Ratings